Bristol-Myers falls as U.S. states sue
Bristol-Myers Squibb Co.'s efforts to protect its branded drugs from genetic competition face big potential setbacks, from both the federal and state governments in the U.S.
Bristol-Myers Squibb Co.'s efforts to protect its branded drugs from genetic competition face big potential setbacks, from both the federal and state governments in the U.S.